Literature DB >> 34595945

Validation of EHR medication fill data obtained through electronic linkage with pharmacies.

Saul Blecker1, Samrachana Adhikari2, Hanchao Zhang2, John A Dodson1, Sunita M Desai2, Lisa Anzisi3, Lily Pazand4, Antoinette M Schoenthaler1, Devin M Mann1.   

Abstract

BACKGROUND: Recent linkages between electronic health records (EHRs) and pharmacy data hold opportunity for up-to-date assessment of medication adherence at the point of care.
OBJECTIVE: To validate linked EHR-pharmacy data, which can be used for point-of-care interventions for concordance with insurance claims data for patients in a large health care delivery system.
METHODS: We performed a retrospective cohort study of adult patients with an active antihypertensive medication order and seen as outpatients between August 25, 2019, and August 31, 2019. Pharmacy fill information was obtained from the EHR via linkages with Surescripts pharmacy and pharmacy benefit manager data, as well as from insurance claims available at our institution. We matched antihypertensive medication fills observed in the linked EHR-pharmacy database with available fills in the insurance claims database and calculated the percentage of medication fills that were available in each database. We estimated medication adherence using proportion of days covered in the linked EHR-pharmacy database and in the insurance claims database.
RESULTS: Of 26,679 patients with hypertension, 23,348 (87.5%) had at least 1 antihypertensive medication fill recorded in the linked EHR-pharmacy database. Of 1,501 patients matched with the insurance database and with a documented medication fill, a fill was present for 1,484 (98.9%) and 1,259 (83.9%) patients in the linked EHR-pharmacy and insurance databases, respectively. Of 12,109 medication fills recorded in the insurance data, we found an overlap of 11,060 (91.3%) fills with the linked EHR-pharmacy database. The linked EHR-pharmacy database also contained 18,232 of 19,281 (94.6%) medication fills present in either database. Measured medication adherence was higher for patients when based on linked EHR-pharmacy data compared with insurance claims data (42% vs 30%, P < 0.001).
CONCLUSIONS: Linked EHR-pharmacy data captured medication fills for the vast majority of patients and resulted in higher estimates of adherence than insurance claims. Our results suggest that pharmacy fill data available in the EHR have sufficient reliability to be used for point-of-care assessment of medication adherence. DISCLOSURES: This study was supported by grant R01HL155149 from the National Heart, Lung, and Blood Institute. Allen Thorpe provided funding for the NYU Langone Health Learning Health System Program, which helped fund this project. The authors have nothing to disclose.

Entities:  

Mesh:

Year:  2021        PMID: 34595945      PMCID: PMC8759289          DOI: 10.18553/jmcp.2021.27.10.1482

Source DB:  PubMed          Journal:  J Manag Care Spec Pharm


  20 in total

1.  Clinical outcomes and adherence to medications measured by claims data in patients with diabetes.

Authors:  Manel Pladevall; L Keoki Williams; Lisa Ann Potts; George Divine; Hugo Xi; Jennifer Elston Lafata
Journal:  Diabetes Care       Date:  2004-12       Impact factor: 19.112

2.  Validation of patient reports, automated pharmacy records, and pill counts with electronic monitoring of adherence to antihypertensive therapy.

Authors:  P W Choo; C S Rand; T S Inui; M L Lee; E Cain; M Cordeiro-Breault; C Canning; R Platt
Journal:  Med Care       Date:  1999-09       Impact factor: 2.983

3.  Contemporary rates and correlates of statin use and adherence in nondiabetic adults with cardiovascular risk factors: The KP CHAMP study.

Authors:  Alan S Go; Dongjie Fan; Sue Hee Sung; Alda I Inveiss; Victoria Romo-LeTourneau; Usha G Mallya; Susan Boklage; Joan C Lo
Journal:  Am Heart J       Date:  2017-08-24       Impact factor: 4.749

Review 4.  Adherence to cardiovascular medications: lessons learned and future directions.

Authors:  Ian M Kronish; Siqin Ye
Journal:  Prog Cardiovasc Dis       Date:  2013-03-23       Impact factor: 8.194

5.  Prescriber continuity and medication adherence for complex patients.

Authors:  Richard A Hansen; Corrine I Voils; Joel F Farley; Benjamin J Powers; Linda L Sanders; Betsy Sleath; Matthew L Maciejewski
Journal:  Ann Pharmacother       Date:  2014-12-30       Impact factor: 3.154

6.  Transitional adherence and persistence in the use of aldosterone antagonist therapy in patients with heart failure.

Authors:  Lesley H Curtis; Xiaojuan Mi; Laura G Qualls; Devon K Check; Bradley G Hammill; Stephen C Hammill; Paul A Heidenreich; Frederick A Masoudi; Soko Setoguchi; Adrian F Hernandez; Gregg C Fonarow
Journal:  Am Heart J       Date:  2013-04-18       Impact factor: 4.749

7.  Contrasting measures of adherence with simple drug use, medication switching, and therapeutic duplication.

Authors:  Bradley C Martin; Elizabeth K Wiley-Exley; Shirley Richards; Marisa E Domino; Timothy S Carey; Betsy Lynn Sleath
Journal:  Ann Pharmacother       Date:  2009-01-06       Impact factor: 3.154

8.  Primary Nonadherence to Overactive Bladder Medications in an Integrated Managed Care Health Care System.

Authors:  Nazia Rashid; Maria Vassilakis; Kathy J Lin; Rita Kristy; Daniel B Ng
Journal:  J Manag Care Spec Pharm       Date:  2017-04

9.  COVID-19 transforms health care through telemedicine: Evidence from the field.

Authors:  Devin M Mann; Ji Chen; Rumi Chunara; Paul A Testa; Oded Nov
Journal:  J Am Med Inform Assoc       Date:  2020-07-01       Impact factor: 4.497

10.  Predicting Adherence to Chronic Disease Medications in Patients with Long-term Initial Medication Fills Using Indicators of Clinical Events and Health Behaviors.

Authors:  Julie C Lauffenburger; Jessica M Franklin; Alexis A Krumme; William H Shrank; Olga S Matlin; Claire M Spettell; Gregory Brill; Niteesh K Choudhry
Journal:  J Manag Care Spec Pharm       Date:  2018-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.